KEGG   DRUG: Visilizumab
Entry
D06314                      Drug                                   

Name
Visilizumab (USAN/INN);
Nuvion (TN)
Efficacy
Immunosuppressant, Anti-CD3 antibody
Comment
Monoclonal antibody
Treatment of organ transplantation rejection and other T lymphocyte-mediated diseases and disorders, including autoimmune diseases
Target
CD3 [HSA:915 916 917] [KO:K06450 K06451 K06452]
  Pathway
hsa04660  T cell receptor signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD3
     D06314  Visilizumab (USAN/INN)
Other DBs
CAS: 219716-33-3
PubChem: 47207971
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system